(Reuters) - The laser device works by correcting for all the
nearsightedness to help distance vision in a patient's dominant
eye, while fixing only part of the nearsightedness in the less
dominant eye, which helps close-up vision, the FDA said.
The FDA said it asked that the company conduct a study
tracking 500 patients for six months after surgery, to check
for potential visual disturbances that could limit activities
or worsen a patient's quality of life.
Read more at Reuters.com Government Filings News
nearsightedness to help distance vision in a patient's dominant
eye, while fixing only part of the nearsightedness in the less
dominant eye, which helps close-up vision, the FDA said.
The FDA said it asked that the company conduct a study
tracking 500 patients for six months after surgery, to check
for potential visual disturbances that could limit activities
or worsen a patient's quality of life.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment